Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease

Increased serum soluble PD-l1 levels in patients with advanced stages of chronic kidney disease

BackgroundProgramed death-ligand 1 (PD-L1) is overexpressed on renal tubular and vascular epithelial cells in inflammatory kidney diseases as well as on aged kidney podocytes, contributing to chronic kidney disease (CKD) progression. The association of serum soluble programed death-ligand 1 (sPD-L1)...

Full description

Saved in:
Bibliographic Details
Main Authors: Ayaka Hayashi, Hiroto Ishihara, Mayuko Kawabe, Kazuhiko Kato, Akio Nakashima, Izumi Yamamoto, Teppei Sakano, Hiroe Kobashi, Makoto Morita, Takashi Yokoo, Mitsuyoshi Urashima
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
PD-1
PD-L1
chronic kidney disease
dialysis
immune checkpoint inhibitor
soluble PD-L1 (sPD-L1)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1530804/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1530804/full

Similar Items